Microbot Medical Stock Total Asset

MBOT Stock

USD 2.55 0.02 0.79%

Microbot Medical's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Microbot Stock price.

	Last Reported	Projected for Next Year
Total Assets	6 M	5.7 M
Intangibles To Total Assets	0.08	0.06

Total Assets is likely to drop to about 5.7 M in 2025. Intangibles To Total Assets is likely to drop to 0.06 in 2025.

Build AI portfolio with Microbot Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Microbot Medical Company Total Asset Analysis

Microbot Medical's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Total Asset

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current Microbot Medical Total Asset

6.03 M

Most of Microbot Medical's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Microbot Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Microbot Total Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Microbot Medical is extremely important. It helps to project a fair market value of Microbot Stock properly, considering its historical fundamentals such as Total Asset. Since Microbot Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Microbot Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Microbot Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Short Term Investments	Common Stock	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Property Plant Equipment	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.66	-0.74	-0.6	0.06	0.07	0.71	0.98	0.59	0.01	0.38	-0.38	0.41	0.54	0.65	0.49	0.43	0.61	0.61	0.63	-0.39
Total Stockholder Equity	0.66		-0.93	0.17	-0.12	-0.06	-0.07	0.78	-0.05	0.36	-0.21	0.05	0.9	-0.18	-0.02	0.02	-0.05	0.15	0.88	0.88	-0.09
Net Debt	-0.74	-0.93		-0.04	-0.01	0.1	-0.11	-0.83	-0.16	-0.16	0.05	-0.08	-0.78	-0.03	-0.11	-0.1	-0.05	-0.26	-0.84	-0.84	0.24
Retained Earnings	-0.6	0.17	-0.04		-0.08	-0.13	-0.95	-0.44	-0.68	0.31	-0.8	0.65	0.36	-0.79	-0.88	-0.66	-0.64	-0.63	0.11	0.08	0.34
Accounts Payable	0.06	-0.12	-0.01	-0.08		0.04	0.19	0.04	0.15	-0.17	0.08	-0.06	-0.29	0.25	0.28	0.21	0.23	0.11	-0.09	-0.09	-0.3
Net Receivables	0.07	-0.06	0.1	-0.13	0.04		0.15	0.05	0.2	0.16	-0.02	-0.37	-0.01	0.1	0.07	-0.02	0.08	0.13	-0.21	-0.22	0.35
Total Liab	0.71	-0.07	-0.11	-0.95	0.19	0.15		0.56	0.83	-0.32	0.7	-0.55	-0.31	0.88	0.87	0.63	0.62	0.67	-0.03	0.0	-0.43
Total Current Assets	0.98	0.78	-0.83	-0.44	0.04	0.05	0.56		0.51	0.06	0.2	-0.26	0.56	0.43	0.5	0.33	0.3	0.49	0.73	0.74	-0.32
Short Term Debt	0.59	-0.05	-0.16	-0.68	0.15	0.2	0.83	0.51		-0.33	0.37	-0.42	-0.26	0.92	0.65	0.28	0.38	0.54	-0.01	0.01	-0.32
Short Term Investments	0.01	0.36	-0.16	0.31	-0.17	0.16	-0.32	0.06	-0.33		-0.39	-0.1	0.27	-0.59	-0.13	-0.05	-0.41	0.32	0.02	0.01	0.09
Common Stock	0.38	-0.21	0.05	-0.8	0.08	-0.02	0.7	0.2	0.37	-0.39		-0.53	-0.39	0.52	0.74	0.66	0.56	0.54	-0.09	-0.06	-0.35
Current Deferred Revenue	-0.38	0.05	-0.08	0.65	-0.06	-0.37	-0.55	-0.26	-0.42	-0.1	-0.53		0.23	-0.45	-0.74	-0.57	-0.57	-0.62	0.17	0.16	-0.01
Net Tangible Assets	0.41	0.9	-0.78	0.36	-0.29	-0.01	-0.31	0.56	-0.26	0.27	-0.39	0.23		-0.35	-0.34	-0.25	-0.18	-0.22	0.83	0.81	0.22
Long Term Debt Total	0.54	-0.18	-0.03	-0.79	0.25	0.1	0.88	0.43	0.92	-0.59	0.52	-0.45	-0.35		0.73	0.43	0.61	0.43	-0.04	-0.02	-0.34
Capital Surpluse	0.65	-0.02	-0.11	-0.88	0.28	0.07	0.87	0.5	0.65	-0.13	0.74	-0.74	-0.34	0.73		0.82	0.68	0.82	-0.04	0.0	-0.48
Deferred Long Term Liab	0.49	0.02	-0.1	-0.66	0.21	-0.02	0.63	0.33	0.28	-0.05	0.66	-0.57	-0.25	0.43	0.82		0.83	0.7	-0.06	-0.03	-0.49
Property Plant Equipment	0.43	-0.05	-0.05	-0.64	0.23	0.08	0.62	0.3	0.38	-0.41	0.56	-0.57	-0.18	0.61	0.68	0.83		0.37	-0.06	-0.03	-0.26
Short Long Term Debt	0.61	0.15	-0.26	-0.63	0.11	0.13	0.67	0.49	0.54	0.32	0.54	-0.62	-0.22	0.43	0.82	0.7	0.37		-0.06	-0.02	-0.48
Net Invested Capital	0.61	0.88	-0.84	0.11	-0.09	-0.21	-0.03	0.73	-0.01	0.02	-0.09	0.17	0.83	-0.04	-0.04	-0.06	-0.06	-0.06		1.0	-0.15
Net Working Capital	0.63	0.88	-0.84	0.08	-0.09	-0.22	0.0	0.74	0.01	0.01	-0.06	0.16	0.81	-0.02	0.0	-0.03	-0.03	-0.02	1.0		-0.18
Capital Stock	-0.39	-0.09	0.24	0.34	-0.3	0.35	-0.43	-0.32	-0.32	0.09	-0.35	-0.01	0.22	-0.34	-0.48	-0.49	-0.26	-0.48	-0.15	-0.18

Click cells to compare fundamentals

Microbot Total Asset Historical Pattern

Today, most investors in Microbot Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Microbot Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Microbot Medical total asset as a starting point in their analysis.

Microbot Medical Total Asset

Timeline

Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Competition

Predict Microbot Medical

Total Assets Over Time

Microbot Total Assets

Total Assets

5.73 Million

At this time, Microbot Medical's Total Assets are comparatively stable compared to the past year.

Based on the latest financial disclosure, Microbot Medical has a Total Asset of 6.03 M. This is 99.92% lower than that of the Health Care Equipment & Supplies sector and 99.82% lower than that of the Health Care industry. The total asset for all United States stocks is 99.98% higher than that of the company.

Microbot Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microbot Medical's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Microbot Medical could also be used in its relative valuation, which is a method of valuing Microbot Medical by comparing valuation metrics of similar companies.

Microbot Medical is currently under evaluation in total asset category among its peers.

Microbot Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Microbot Medical from analyzing Microbot Medical's financial statements. These drivers represent accounts that assess Microbot Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Microbot Medical's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	49.0M	53.3M	21.9M	16.7M	17.5M	16.6M
Enterprise Value	30.2M	40.5M	19.9M	14.5M	14.5M	13.8M

Microbot Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Microbot Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Microbot Medical's managers, analysts, and investors.

Environmental

Governance

Social

Microbot Medical Institutional Holders

Institutional Holdings refers to the ownership stake in Microbot Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Microbot Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Microbot Medical's value.

		Shares
Goldman Sachs Group Inc	2025-03-31	37.7 K
Hilltop Holdings Inc	2025-03-31	33.7 K
Virtu Financial Llc	2025-03-31	27.7 K
Thoroughbred Financial Services, Llc	2025-03-31	27 K
Scotia Capital Inc	2025-03-31	22.8 K
Morgan Stanley - Brokerage Accounts	2025-03-31	21 K
Tower Research Capital Llc	2025-03-31	16.2 K
Beacon Capital Management, Llc	2025-06-30	16 K
Jane Street Group Llc	2025-03-31	15.6 K
Vanguard Group Inc	2025-03-31	741.2 K
Geode Capital Management, Llc	2025-03-31	316.9 K

Microbot Fundamentals

	Return On Equity	-0.66
	Return On Asset	-0.4
	Current Valuation	70.93 M
	Shares Outstanding	39.99 M
	Shares Owned By Institutions	6.25 %
	Number Of Shares Shorted	7.96 M
	Price To Earning	(3.42) X
	Price To Book	3.49 X
	EBITDA	(11.35 M)
	Net Income	(11.44 M)
	Cash And Equivalents	9.29 M
	Cash Per Share	1.31 X
	Total Debt	111 K
	Debt To Equity	0.07 %
	Current Ratio	5.60 X
	Book Value Per Share	0.83 X
	Cash Flow From Operations	(8.83 M)
	Short Ratio	7.72 X
	Earnings Per Share	(0.64) X
	Target Price	9.0
	Number Of Employees	20
	Beta	1.13
	Market Capitalization	101.18 M
	Total Asset	6.03 M
	Retained Earnings	(90.94 M)
	Working Capital	3.36 M
	Current Asset	15.21 M
	Current Liabilities	9.83 M
	Net Asset	6.03 M

About Microbot Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Microbot Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbot Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbot Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC